TuHURA Biosciences HURA
NASDAQ HURA
$1.52 +0.01 (+0.66%)
At close: Nov 11, 2026 · 4:00 PM EST

TuHURA Biosciences (HURA) Current Leases (2023 - 2026)

Updated

Analysis

TuHURA Biosciences (HURA) Current Leases (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 TuHURA Biosciences 96.16 Mn 82.54 Mn - 214,175.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 214,175.00
Mar 31, 2026 206,851.00
Dec 31, 2025 199,041.00
Sep 30, 2025 84,346.00
Jun 30, 2025 124,969.00
Mar 31, 2025 164,594.00
Dec 31, 2024 159,844.00
Dec 31, 2023 20,820.00
API Access

TuHURA Biosciences Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=HURA&period=max&api_key=YOUR_API_KEY